Patients are often the last to know that a drug has been recalled or that the products may have dangerous side effects, especially when taken with other drugs, a study published Thursday shows.
Dr. Gordon Schiff and his colleagues at Cook County Hospital in Chicago found that some patients kept taking the cholesterol-lowering drug Baycol (cerivastatin) for weeks after it had been recalled and that many were prescribed another cholesterol-cutter, gemfibrozil, despite repeated warnings about its potential to increase the risk of a muscle-wasting condition called rhabdomyolysis.
תגובות רוצה להצטרף לדיון?
יש להתחבר כדי להגיב.
התחבראין תגובות עדיין. היה הראשון להגיב!